Replies to post #646350 on NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

And also on page 25, I love this.
Between May and September 2023, the Company entered into certain non-dilutive funding agreements with multiple investors, pursuant to which the Company received funding of $4.6 million related to a gain contingency. These agreements are accounted for under ASC 470 and are recognized as contingent payment obligations on the Company’s condensed consolidated balance sheet. The Company’s payment obligations only apply when such are received by the Company.

And on that note, whatever that...

"contingent payment obligation"

...pertains to (and I have my strong suspicions), it's a new line this year. In the previous Q, page 7, it read $4,050,000, and this Q, that section went up by $500k.

So what is a "Contingent Payment Obligation"?
According to "Westlaw", the definition reads:

An obligation that is not presently fixed and absolute, but which will become so on the happening of some future and uncertain event. A guarantee obligation is an example of a contingent obligation.Under the terms of the guarantee, the guarantor assumes liability for all guaranteed obligations, but its liability to make payments is conditional. In a guarantee, the contingency is typically the failure of the party that is primarily responsible for the payment obligations to make payment. If this occurs, the guarantor's payment obligation is no longer contingent.